Loading... Please wait...

Clinical Trial Shows Ataluren Can Slow Down the Progression of Duchenne Muscular Dystrophy

Posted by

20 July 2017

The results of an international clinical trial show that a drug therapy for a severe type of muscular dystrophy holds promise for a subgroup of patients with Duchenne muscular dystrophy. The trial was led in part by Craig McDonald, a UC Davis School of medicine expert.

“What’s very encouraging about these findings is that a treatment using ataluren for certain individuals with Duchenne muscular dystrophy may prompt a slowing or stabilizing of the disease progression and motor function that can be very meaningful to patients and provide them with invaluable, quality-of-life benefits,” McDonald said.

To read more: http://www.davisenterprise.com/local-news/clinical...